Ursodiol Tablet
Product Images NDC 68001-377

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 68001-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ursodiol Tablets Usp 250 mg.jpg (250mg)

Ursodiol Tablets USP 250 mg oral tablet label for a 100-count jar. The label includes the NDC 68001-377-00 and indicates the product is by BluePoint Laboratories. It states storage conditions, dosage recommendations, and cautions. The label size is 105 mm by 45 mm for a 100 cc jar.*

FDA Label Image

Ursodiol Tablets Usp 500 mg.jpg (500mg)

Packaging label for Ursodiol Tablets USP 500 mg oral tablets by BluePoint Laboratories. The label indicates a 100-tablet count, with manufacturing by Glenmark Pharmaceuticals Ltd. It includes dosage instructions, storage conditions, and a barcode. The label notes use for the treatment of Primary Biliary Cirrhosis and is marked Rx only.*

FDA Label Image

Section 11 Figure (Structure)

Chemical structure of Ursodiol, showing its molecular arrangement with hydroxyl groups and carboxyl group characteristic of this bile acid derivative active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.